This webinar provides a virtual demonstration of the BioSMB multi-column chromatography platform — a fully scalable single-use solution that reduces resin usage and enables manufacturers to explore continuous processing. The demo starts with an overview of the BioSMB PD system for small-scale manufacturing and then continues with the BioSMB Process systems for clinical and commercial manufacturing. Click here to watch this virtual demonstration.
CDMO VGXI will increase plasmid DNA capacity by over 500% through an investment at a site in Conroe, Texas. The contract development manufacturing organization (CDMO) did not divulge any financial details associated with its new headquarters and manufacturing plant. However, the facility will be located at Deison Technology Park in Conroe, Texas on a 21.5-acre area of land. “The new facility is purpose built to support VGXI’s optimized Plasmid DNA production process at expanded scales and across multiple flexible manufacturing…
Collaboration, supply chain resilience, acknowledgement they work, and trust will drive the cell and gene therapy sector going forward, EY’s Adlai Goldberg says on the latest episode of the BioProcess Insider Expression Platform. The cell and gene therapy sector is on the cusp of flourishing in the vast pharma landscape. Money is flowing in, manufacturing challenges are being overcome, people are actually being treated and cured. Even COVID-19 may be seen as a driving force for the burgeoning sector. But…